Onkolyze
Singapore
About Onkolyze
Onkolyze helps doctors personalise chemotherapy treatment. Using data already captured as part of the clinical workflow, Onkolyze allows doctors to simulate patient specific outcomes for different chemotherapy treatments. This is achieved by unique combination of computer vision, artificial intelligence, and computer simulations. Optimising cancer treatment for individuals improves patient outcomes and saves the healthcare ecosystem money.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (Jul 2018)
- Website: onkolyze.com
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science, Software
Social Profiles
Canonical: https://fsome.com/organization/onkolyze-2667662 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.